{
  "id": 4416463,
  "title": "Arthritis drug restores 100% of hair on some patients with severe alopecia in global trial",
  "url": "https://urgent.news/2026/08/30/arthritis-drug-restores-100-of-hair-on-some-patients-with-severe",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-30T12:00:09.000Z",
  "source": {
    "name": "Reuters Business via SCMP",
    "slug": "reuters-business-via-scmp",
    "url": "https://www.scmp.com/news/china/science/article/3365432/arthritis-drug-restores-100-hair-some-patients-severe-alopecia-global-trial"
  },
  "original_language": "en",
  "account": null,
  "summary": "A new arthritis drug, upadacitinib, has shown promising results in restoring hair growth for patients with severe alopecia areata, a condition characterized by autoimmune hair loss. Conducted by researchers at Harvard University, the global trial involved over 200 participants who experienced an average hair loss of 84% on their scalps. The once-daily oral medication, initially approved for treating arthritis, was found to effectively calm the immune system and promote hair regrowth. Within 24 weeks, half of the participants taking upadacitinib experienced at least 80% regrowth, with over 35% achieving deep regrowth and 20% regaining a completely full head of hair. The drug's safety profile matched its known use in arthritis treatment, with no unexpected side effects reported. While not yet approved specifically for alopecia areata, the findings provide a promising new treatment option for those struggling with this emotionally and socially impactful condition.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "South China Morning Post",
        "title": "Arthritis drug restores 100% of hair on some patients with severe alopecia in global trial",
        "url": "https://urgent.news/2026/08/30/arthritis-drug-restores-100-of-hair-on-some-patients-with-severe-4418467",
        "published": "2026-08-30T12:00:09.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}